Company Filing History:
Years Active: 2021-2024
Title: Innovations by Aleksandr Nikitin
Introduction
Aleksandr Nikitin is a notable inventor based in Khimki, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors related to metabolic disorders. With a total of 2 patents, his work is paving the way for new treatments in medicine.
Latest Patents
Nikitin's latest patents focus on compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide. These compounds are recognized for their potential as agonists of G protein-coupled receptor 119. The patents detail methods and uses related to these compounds, particularly in the treatment of diseases and conditions associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders.
Career Highlights
Aleksandr Nikitin is currently associated with Pramana Pharmaceuticals Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on addressing critical health issues through scientific research and development.
Collaborations
Nikitin collaborates with esteemed colleagues such as Tarek Suhayl Mansour and Mikhail Yudin. Their combined expertise enhances the research and development efforts at Pramana Pharmaceuticals Inc.
Conclusion
Aleksandr Nikitin's contributions to the field of pharmaceuticals through his innovative patents are significant. His work not only showcases his expertise but also holds promise for advancing treatments for metabolic disorders.